Published in Thorax on May 01, 1998
What's new in cystic fibrosis? From treating symptoms to correction of the basic defect. Eur J Pediatr (2008) 0.99
Bone Mineral Density in Cystic Fibrosis Patients with the CFTR I1234V Mutation in a Large Kindred Family Is Associated with Pancreatic Sufficiency. Int J Rheumatol (2014) 0.79
Genetics and pulmonary medicine 8: asthma. Thorax (1999) 0.78
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
A peptide antibiotic from human skin. Nature (1997) 7.64
Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell (1996) 6.84
Peptide antibiotics. Lancet (1997) 6.76
Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med (1995) 6.56
CFTR as a cAMP-dependent regulator of sodium channels. Science (1995) 6.50
Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell (1997) 5.99
Cystic fibrosis. Am J Respir Crit Care Med (1996) 4.56
Cystic fibrosis: molecular biology and therapeutic implications. Science (1992) 3.72
Defective acidification of intracellular organelles in cystic fibrosis. Nature (1991) 3.66
Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science (1996) 3.38
Pathology of cystic fibrosis review of the literature and comparison with 146 autopsied cases. Perspect Pediatr Pathol (1975) 3.03
Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J Clin Invest (1993) 3.00
Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat Genet (1992) 2.79
Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet (1996) 2.65
Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Natl Acad Sci U S A (1997) 2.51
Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects. J Clin Invest (1997) 2.47
Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease. Proc Natl Acad Sci U S A (1997) 2.24
Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest (1997) 2.10
Early alterations in airway mucociliary clearance and inflammation of the lamina propria in CF mice. Am J Physiol (1997) 1.54
A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. Gene Ther (1996) 1.49
Asialo GM1 is a receptor for Pseudomonas aeruginosa adherence to regenerating respiratory epithelial cells. Infect Immun (1996) 1.48
Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am J Respir Crit Care Med (1994) 1.44
Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nat Genet (1995) 1.37
The mouse genome encodes a single homolog of the antimicrobial peptide human beta-defensin 1. FEBS Lett (1997) 1.21
Fibrocystic disease of the pancreas in the newborn. Arch Dis Child (1956) 1.17
Towards an ovine model of cystic fibrosis. Hum Mol Genet (1997) 1.11
Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens. Hum Mol Genet (1997) 1.09
Alternate translation initiation codons can create functional forms of cystic fibrosis transmembrane conductance regulator. J Biol Chem (1995) 1.08
Complexity in a monogenic disease. Nat Genet (1996) 1.08
Mucociliary transport in trachea of patients with cystic fibrosis. Arch Dis Child (1976) 1.04
Rheological and transport properties of airway secretions in cystic fibrosis--relationships with the degree of infection and severity of the disease. Eur J Clin Invest (1985) 0.93
The cystic fibrosis transmembrane conductance regulator and ATP. Curr Opin Cell Biol (1997) 0.93
CFTR gene transfer reduces the binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium. Am J Respir Cell Mol Biol (1997) 0.88
Cystic fibrosis: gene therapy or preventive gene transfer? Gene Ther (1997) 0.78
New pharmaceutical approaches to the treatment of cystic fibrosis. Nat Med (1996) 0.76
Cystic fibrosis lung infection cleared up? Nat Med (1997) 0.76
Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet (2000) 7.16
Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet (2001) 4.77
Genome-wide association studies establish that human intelligence is highly heritable and polygenic. Mol Psychiatry (2011) 4.16
The DISC locus in psychiatric illness. Mol Psychiatry (2007) 3.46
SUSPECTS: enabling fast and effective prioritization of positional candidates. Bioinformatics (2006) 2.96
WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci U S A (2001) 2.79
Splinkerettes--improved vectorettes for greater efficiency in PCR walking. Nucleic Acids Res (1995) 2.51
Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Thorax (2007) 1.93
Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol Psychiatry (2001) 1.81
High-resolution localization of 69 potential human zinc finger protein genes: a number are clustered. Genomics (1992) 1.74
A locus for bipolar affective disorder on chromosome 4p. Nat Genet (1996) 1.67
A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. Gene Ther (1996) 1.49
Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Mol Psychiatry (2005) 1.41
A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D. Cancer Res (2000) 1.39
Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nat Genet (1995) 1.37
Disrupted in Schizophrenia 1 (DISC1) is a multicompartmentalized protein that predominantly localizes to mitochondria. Mol Cell Neurosci (2004) 1.35
Control of the flux in the arginine pathway of Neurospora crassa. Modulations of enzyme activity and concentration. Biochem J (1981) 1.35
Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder. Psychiatr Genet (2001) 1.30
Interacting haplotypes at the NPAS3 locus alter risk of schizophrenia and bipolar disorder. Mol Psychiatry (2008) 1.27
Association of Neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population. Mol Psychiatry (2006) 1.23
Molecular analysis of chromosome 11 deletions in aniridia-Wilms tumor syndrome. Proc Natl Acad Sci U S A (1985) 1.22
CFTR and calcium-activated chloride currents in pancreatic duct cells of a transgenic CF mouse. Am J Physiol (1994) 1.20
Molecular and physical arrangements of human DNA in HRAS1-selected, chromosome-mediated transfectants. Mol Cell Biol (1986) 1.17
Control of the flux in the arginine pathway of Neurospora crassa. The flux from citrulline to arginine. Biochem J (1980) 1.16
Association between genotype at an exonic SNP in DISC1 and normal cognitive aging. Neurosci Lett (2005) 1.15
Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum. Gene Ther (1998) 1.14
Rethinking the genetic architecture of schizophrenia. Psychol Med (2010) 1.13
Sendai virus-mediated CFTR gene transfer to the airway epithelium. Gene Ther (2007) 1.13
Disruption of a brain transcription factor, NPAS3, is associated with schizophrenia and learning disability. Am J Med Genet B Neuropsychiatr Genet (2005) 1.13
Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations. EMBO J (1996) 1.13
Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder. Mol Psychiatry (2006) 1.12
Adenoviral augmentation of elafin protects the lung against acute injury mediated by activated neutrophils and bacterial infection. J Immunol (2001) 1.11
HRAS1-selected chromosome transfer generates markers that colocalize aniridia- and genitourinary dysplasia-associated translocation breakpoints and the Wilms tumor gene within band 11p13. Proc Natl Acad Sci U S A (1987) 1.11
Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung. Gene Ther (2011) 1.10
A genome scan and follow-up study identify a bipolar disorder susceptibility locus on chromosome 1q42. Mol Psychiatry (2004) 1.08
Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor. Mol Psychiatry (2005) 1.07
Long-term survival of the exon 10 insertional cystic fibrosis mutant mouse is a consequence of low level residual wild-type Cftr gene expression. Mamm Genome (1994) 1.06
Restriction fragment length polymorphism analysis and assignment of the metalloproteinases stromelysin and collagenase to the long arm of chromosome 11. Genomics (1988) 1.02
Subcellular targeting of DISC1 is dependent on a domain independent from the Nudel binding site. Mol Cell Neurosci (2005) 1.01
Nuts and bolts of psychiatric genetics: building on the Human Genome Project. Trends Genet (2001) 1.01
Non-viral vectors in cystic fibrosis gene therapy: progress and challenges. Trends Biotechnol (2004) 1.00
Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res (1996) 0.99
A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome. Proc Natl Acad Sci U S A (1999) 0.98
Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level. Br J Cancer (1988) 0.97
Transcriptional regulation of neurodevelopmental and metabolic pathways by NPAS3. Mol Psychiatry (2011) 0.96
A common variant in the 3'UTR of the GRIK4 glutamate receptor gene affects transcript abundance and protects against bipolar disorder. Proc Natl Acad Sci U S A (2008) 0.96
Some principles and practices of genetic biobanking studies. Eur Respir J (2009) 0.95
Selection for precise chromosomal targeting of a dominant marker by homologous recombination. Science (1989) 0.94
BARX2 induces cadherin 6 expression and is a functional suppressor of ovarian cancer progression. Cancer Res (2001) 0.94
Association of DISC1 variants with age of onset in a population-based sample of recurrent major depression. Mol Psychiatry (2012) 0.94
Hitch-hiking from HRAS1 to the WAGR locus with CMGT markers. Nucleic Acids Res (1988) 0.93
Gene mapping and physical arrangements of human chromatin in transformed, hybrid cells: fluorescent and autoradiographic in situ hybridization compared. Somat Cell Mol Genet (1986) 0.93
GWAS for psychiatric disease: is the framework built on a solid foundation? Mol Psychiatry (2009) 0.93
The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia. Mol Psychiatry (2001) 0.92
A 6.9-Mb high-resolution BAC/PAC contig of human 4p15.3-p16.1, a candidate region for bipolar affective disorder. Genomics (2001) 0.91
Regulation of adenovirus-mediated elafin transgene expression by bacterial lipopolysaccharide. Hum Gene Ther (2001) 0.91
Correlation between nasal potential difference measurements, genotype and clinical condition in patients with cystic fibrosis. Eur Respir J (1997) 0.91
Heritability of chronic pain in 2195 extended families. Eur J Pain (2012) 0.90
Identification of genes from a schizophrenia-linked translocation breakpoint region. Genomics (2001) 0.90
Chromosomal abnormalities and mental illness. Mol Psychiatry (2003) 0.90
Mapping of retrotransposon sequences in the unstable region surrounding the spinal muscular atrophy locus in 5q13. Genomics (1995) 0.89
Bioelectric characteristics of exon 10 insertional cystic fibrosis mouse: comparison with humans. Am J Physiol (1995) 0.89
Variation in DISC1 is associated with anxiety, depression and emotional stability in elderly women. Mol Psychiatry (2010) 0.87
CpG islands surround a DNA segment located between translocation breakpoints associated with genitourinary dysplasia and aniridia. Genomics (1989) 0.87
Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungs. Gene Ther (2000) 0.87
Plasmid DNA molecules complexed with cationic liposomes are protected from degradation by nucleases and shearing by aerosolisation. Gene Ther (1996) 0.86
Association analysis of the chromosome 4p15-p16 candidate region for bipolar disorder and schizophrenia. Mol Psychiatry (2007) 0.86
YAC mapping by FISH using Alu-PCR-generated probes. Genomics (1992) 0.85
Synaptic modulators Nrxn1 and Nrxn3 are disregulated in a Disc1 mouse model of schizophrenia. Mol Psychiatry (2011) 0.85
Optimising gene repair strategies in cell culture. Gene Ther (2002) 0.84
Cytogenetics and gene discovery in psychiatric disorders. Pharmacogenomics J (2005) 0.84
Co-ordinated action of DISC1, PDE4B and GSK3β in modulation of cAMP signalling. Mol Psychiatry (2011) 0.84
Insertion of natural intron 6a-6b into a human cDNA-derived gene therapy vector for cystic fibrosis improves plasmid stability and permits facile RNA/DNA discrimination. J Gene Med (2000) 0.84
Identification and characterization of a homozygous deletion found in ovarian ascites by representational difference analysis. Genome Res (1999) 0.84
Rapid and quantitative detection of unique sequence donor DNA in extracts of cultured mammalian cells: an aid to chromosome mapping. Somat Cell Mol Genet (1985) 0.84
A cosmid clone map derived from a small region of human chromosome 11. Genomics (1989) 0.84
Analysis of WAGR deletions and related translocations with gene-specific DNA probes, using FACS-selected cell hybrids. Somat Cell Mol Genet (1988) 0.83
Convergence of linkage, association and GWAS findings for a candidate region for bipolar disorder and schizophrenia on chromosome 4p. Mol Psychiatry (2010) 0.83
Towards gene therapy for cystic fibrosis: a clinical progress report. Gene Ther (1998) 0.83
Predicting cognitive ability in ageing cohorts using Type 2 diabetes genetic risk. Diabet Med (2014) 0.83
Rapid isolation and characterization of hybridization selected recombinants from lambda genomic libraries. Anal Biochem (1986) 0.82
Coincident sequence cloning. Nucleic Acids Res (1991) 0.82
High frequency gene targeting using insertional vectors. Hum Mol Genet (1993) 0.82
Cloning the shared components of complex DNA resources. Hum Mol Genet (1994) 0.81
Enhancing the efficiency of introducing precise mutations into the mouse genome by hit and run gene targeting. Transgenic Res (2000) 0.81
Gene therapy for lung inflammatory diseases: not so far away? Thorax (1997) 0.81
Functional correction of episomal mutations with short DNA fragments and RNA-DNA oligonucleotides. J Gene Med (2002) 0.81
Is bipolar disorder more common in highly intelligent people? A cohort study of a million men. Mol Psychiatry (2012) 0.81
Gene targeting for somatic cell manipulation: rapid analysis of reduced chromosome hybrids by Alu-PCR fingerprinting and chromosome painting. Hum Mol Genet (1992) 0.81
Schizophrenia-associated chromosome 11q21 translocation: identification of flanking markers and development of chromosome 11q fragment hybrids as cloning and mapping resources. Am J Hum Genet (1993) 0.80
Genomic sequence analysis of Fugu rubripes CFTR and flanking genes in a 60 kb region conserving synteny with 800 kb of human chromosome 7. Genome Res (2000) 0.80
Human repeat-mediated integration of selectable markers into somatic cell hybrids. Genome Res (1995) 0.80
Markers close to the dopamine D5 receptor gene (DRD5) show significant association with schizophrenia but not bipolar disorder. Am J Med Genet (2001) 0.80
Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy. Gene Ther (1995) 0.80
Effect of IBMX and alkaline phosphatase inhibitors on Cl- secretion in G551D cystic fibrosis mutant mice. Am J Physiol (1998) 0.80
Physical mapping of a glutamate receptor gene in relation to a balanced translocation associated with schizophrenia in a large Scottish family. Psychiatr Genet (1997) 0.80
Novel transcribed sequences neighbouring a translocation breakpoint associated with schizophrenia. Am J Med Genet (1997) 0.80
Alu-based vectorettes and splinkerettes. More efficient and comprehensive polymerase chain reaction amplification of human DNA from complex sources. Genet Anal Tech Appl (1994) 0.79